A recent study in mice reveals that treatment using an antibody, called anti-CD137, enhances the immune system’s response against multiple myeloma tumors. The positive results of this preclinical study suggest that anti-CD137, a type of cancer immunotherapy, may be suitable for use in human multiple myeloma patients.

Cancer immunotherapy helps the immune system fight cancer.  It has emerged in recent years as an alternative to high-dose chemotherapy and stem cell transplantation treatments.

Following a dose of chemotherapy, immunotherapy is used to stimulate the immune system to defend against residual …